The New England journal of medicine
-
Randomized Controlled Trial Clinical Trial
Effect of long-term monitoring of glycosylated hemoglobin levels in insulin-dependent diabetes mellitus.
The value of routine measurements of glycosylated hemoglobin (hemoglobin A1c) in the care of patients with diabetes mellitus is uncertain. We undertook this study to determine whether knowledge of hemoglobin A1c values would result in improved metabolic control in a group of patients with insulin-dependent diabetes mellitus (IDDM). ⋯ Regular measurements of hemoglobin A1c lead to changes in diabetes treatment and improvement of metabolic control, indicated by a lowering of hemoglobin A1c values.